Investor relations
Interim Results
H1 25 was another period of exceptional progress and continued market outperformance for Elixirr. We achieved five record-breaking months in the first half of the year, highlighting the strength of our service offering and the momentum across the business. This strong performance reinforces our position as a leading challenger consultancy and sets a powerful foundation for the remainder of 2025.
Corporate Governance
Our corporate governance code
The Ordinary Shares are admitted to trading on the Main Market of the London Stock Exchange and, accordingly, Elixirr is required to comply or explain against the UK Corporate Governance Code.
Board Committees
The Board is supported by Audit & Risk, Remuneration and Nomination Committees.
The Committees are responsible for reviewing the effectiveness of their terms of reference, as appropriate, and for making recommendations to the Board for changes where necessary. The minutes of Committee meetings are circulated to all Committee members, and reports on each Committee meeting are given by the Committee chairman to the Board. From time to time, separate committees may be set up by the Board to consider and address specific issues, when the need arises.
Audit & Risk Committee
The Audit & Risk Committee’s responsibilities include, but are not limited to, oversight of financial reporting, facilitation of external audit processes and overseeing that the approach to risk management and internal control is relevant in the context of supporting strategy.
The Audit & Risk Committee comprises: Charlotte Stranner (Chair) and Simon Retter.
Remuneration Committee
The Remuneration Committee reviews the performance of the Executive Directors and sets their remuneration, determines the payment of bonuses to the Executive Directors and considers the Elixirr group’s long-term incentive arrangements. Our remuneration policy aims to attract, retain and motivate high-calibre directors who will create shareholder value.
The Remuneration Committee comprises: Simon Retter (Chair), Gavin Paterson and Charlotte Stranner.
Nomination Committee
The Nomination Committee reviews and recommends nominees as new Directors to the Board. The responsibilities of the Nomination Committee include, but are not limited to, assessing the adequacy of the knowledge and representativeness of Non-Executive Directors, approving the appointment of any new Non-Executive Directors and succession planning for Executive Directors and Senior Management.
The Nomination Committee comprises: Gavin Paterson (Chair), Simon Retter and Charlotte Stranner.
Explore more
The Investor Monthly
Sign up to our monthly newsletter.